Timeline
CVS Group shares rise on bank refinancing and £50m buyback
The Premarket Brief: Sound Energy sells Tendrara stake for $57m, CVS Group, Arrow Exploration, AstraZeneca, Atalaya Mining
Health & Bio Today: GSK drops despite strong Q1, SkinBioTherapeutics, Solvonis, AstraZeneca, Ondine Biomedical
More in Healthcare Services
Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew
A clinical setback dominated the health and biotech session, as AstraZeneca shed more than 7% after its Phase III CARDIO-TTRansform trial of Wainua in heart disease failed to meet its primary endpoint, the most significant event in an otherwise deal- and financing-focused day for the sector.